about
Pathogens Use and Abuse MicroRNAs to Deceive the Immune SystemEpigenetic control of HIV-1 post integration latency: implications for therapyRoles of microRNAs and long-noncoding RNAs in human immunodeficiency virus replicationThe mTOR Complex Controls HIV Latency.Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression.MicroRNA profile analysis of host cells before and after wild human rotavirus infection.A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV.MicroRNA 155 and viral-induced neuroinflammation.MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients.Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells.MiR-139 suppresses β-casein synthesis and proliferation in bovine mammary epithelial cells by targeting the GHR and IGF1R signaling pathways.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.The role of miR-29a in HIV-1 replication and latency.Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.Are microRNAs Important Players in HIV-1 Infection? An Update.Suppression of NF-κB Activity: A Viral Immune Evasion Mechanism
P2860
Q26748918-7D9016CE-225C-4C48-A212-948D8F9E2B9EQ26781191-521CB8B4-4A6F-4526-A772-26EC51A0212AQ26782187-312E1220-45CF-4F58-B9B2-E29B21856BF0Q36225471-160C83A2-7153-43DC-BCA7-0E2AB6E60205Q36228320-EC209D1D-42EF-4AC0-A57D-FB9C7C565EEFQ38450899-45F33B08-01C3-45BB-98BA-819E2E1F4A0AQ38654059-B5C74ED2-6D95-44D4-99D9-C51C1B55279AQ38687781-95BA4C38-AC9B-45AD-A89E-DA9264972D3EQ38757713-7AD49DD3-13E3-4D7D-A162-758AE2321A96Q39111001-FB5B7BB3-AE0E-411B-AD24-0C6B241C394DQ40407547-2EF30556-5F9A-40D4-8411-C73CC1937FDEQ41926635-A3B3C119-0A0D-4FF9-86E5-4C277EB9AA6FQ47139145-AC1DF3AB-34CF-4DCD-BA2A-8E9C37D057BEQ47555946-6C8A6538-5908-4D22-BA50-9C990B7EA7DDQ47604571-5F912457-F88B-4EC9-8094-721C0896324BQ52568482-2D5AC7EE-2CDD-4011-9881-794FB44D6D31Q52671487-E30667E1-93C7-4110-B323-CF36704FC597Q56987882-5453BE19-3E61-4FC6-AC20-E79D44E9E63E
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MicroRNA-155 Reinforces HIV Latency.
@ast
MicroRNA-155 Reinforces HIV Latency.
@en
type
label
MicroRNA-155 Reinforces HIV Latency.
@ast
MicroRNA-155 Reinforces HIV Latency.
@en
prefLabel
MicroRNA-155 Reinforces HIV Latency.
@ast
MicroRNA-155 Reinforces HIV Latency.
@en
P2093
P2860
P356
P1476
MicroRNA-155 Reinforces HIV Latency
@en
P2093
Amy J Heidersbach
Andrew M Hebbeler
Debbie S Ruelas
Jonathan K Chan
Leonard Chavez
Warner C Greene
P2860
P304
13736-13748
P356
10.1074/JBC.M115.641837
P407
P577
2015-04-14T00:00:00Z